Author

C. P. Santiago

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

A. A. Imam· 1 shared A. Price· 1 shared C. G. Eberhart· 1 shared C. J. Keuthan· 1 shared C. Peterson· 1 shared J. D. Ash· 1 shared M. M. McNally· 1 shared M. S. Singh· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. A. Imam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PathologybioRxivPreprintDec 14, 2022

Cellular and Fibrillar Collagen Analyses in an Animal Model of Retinal Detachment-Related Proliferative Vitreoretinopathy Reveals a Defined Transition to Chronic Fibrosis

C. Peterson, C. P. Santiago, Y. Lu…·M. S. Singh

This study uses a rabbit model of retinal detachment to analyze cellular and fibrillar collagen changes, revealing a transition to chronic fibrosis in PVR.

DOI 10.1101/2022.12.14.520462

bulk RNA-seqexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivMar 28, 2018

A drug-tunable gene therapy for broad-spectrum protection against retinal degeneration

C. P. Santiago, C. J. Keuthan, S. Boye…·J. D. Ash

This study develops a drug-tunable gene therapy vector, RPF2, that protects photoreceptors and prevents blindness in mice by controlling transgene expression with trimethoprim.

DOI 10.1016/j.ymthe.2018.07.016

mouseexperimental assay

𝕏 PostBluesky